Release 5 FHIR CI-Build

This page is part of the Continuous Integration Build of FHIR Specification (v5.0.0: R5 - STU ). This is the current published version in it's permanent home (it will always (will be available incorrect/inconsistent at this URL). For a full list of available versions, see times).
See the Directory of published versions . Page versions: R5 R4B

Example ClinicalUseDefinition/example (JSON)

Maturity Level : N/A
Responsible Owner: Biomedical Research and Regulation Work Group Standards Status : Informative Compartments : No defined compartments

Raw JSON ( canonical form + also see JSON Format Specification )

Example of clinicalusedefinition Contraindication example 

{
  "resourceType" : "ClinicalUseDefinition",
  "id" : "example",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: ClinicalUseDefinition</b><a name=\"example\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource ClinicalUseDefinition &quot;example&quot; </p></div><p><b>type</b>: contraindication</p><blockquote><p><b>contraindication</b></p><h3>DiseaseSymptomProcedures</h3><table class=\"grid\"><tr><td>-</td><td><b>Concept</b></td></tr><tr><td>*</td><td>Hepatic disease associated with coagulopathy and clinically relevant bleeding risk <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (contraindicationsasdisease-symptom-procedure#Coagulopathiesandbleedingdiatheses(exclthrombocytopenic))</span></td></tr></table><h3>Comorbidities</h3><table class=\"grid\"><tr><td>-</td><td><b>Concept</b></td></tr><tr><td>*</td><td>Hepaticdisease <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (comorbidity#Hepaticdisease)</span></td></tr></table></blockquote></div>"
  },

  "extension" : [{
    "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
    "valueCode" : "brr"
  }],

  "type" : "contraindication",
  "subject" : [{
    
  }],

  "contraindication" : {
    "diseaseSymptomProcedure" : {
      "concept" : {
        "coding" : [{
          "system" : "http://ema.europa.eu/example/contraindicationsasdisease-symptom-procedure",
          "code" : "Coagulopathiesandbleedingdiatheses(exclthrombocytopenic)"

          "code" : "hepatic-example-code"

        }],
        "text" : "Hepatic disease associated with coagulopathy and clinically relevant bleeding risk"
      }
    },
    "comorbidity" : [{
      "concept" : {
        "coding" : [{
          "system" : "http://ema.europa.eu/example/comorbidity",
          "code" : "Hepaticdisease"
        }]
      }
    }]

    }

  }
}

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.